Virus News and Research

Latest Virus News and Research

Nylon strips an effective weapon against the hospital acquired superbug

Nylon strips, beads and hospital stitching thread covered in viruses could be an effective weapon against the hospital acquired superbug, methicillin-resistant Staphylococcus aureus, known as MRSA, according to research presented today (Tuesday, 05 April 2005) at the Society for General Microbiology's 156th Meeting at Heriot-Watt University, Edinburgh.

4 Apr 2005

How E.Coli became deadly to humans

Twenty-three years ago a harmless gut bacterium called E. coli developed the ability to kill people through food poisoning, bloody diarrhoea and kidney failure. Normally E. coli bacteria live in the intestine and don’t pose any danger, but some varieties can cause fatal food poisoning.

4 Apr 2005

Unravelling the Ebola virus’s biological cycle

Ebola virus infection in humans provokes a violent haemorrhagic fever. It usually flares up as intense epidemics. These kill 80 % of the people infected. Seven such outbreaks have hit Gabon and the Republic of Congo since 1994, leading to 445 cases resulting in 361 deaths.

4 Apr 2005

Study finds direct link between use of alcohol hand gel and reduction in hospital infections

Hospitals whose healthcare workers had access to alcohol gel to disinfect hands had a decreased risk of hospital- associated infections in their patients compared to hospitals whose staff did not have a regular alcohol hand gel program, according to a new study from Children's Hospital and Regional Medical Center in Seattle and published in the April 1 edition of Pediatrics.

4 Apr 2005

Treatment of bronchiolitis in children varies widely and often results in unnecessary tests and antibiotics

Considerable differences exist in the treatment of bronchiolitis at children's hospitals across the United States, according to a study from Children's Hospital and Regional Medical Center in Seattle published in the April 1 issue of Pediatrics.

4 Apr 2005

Oral sex not sex say teens

Many teenagers in the US do not regard oral sex as sex and one in five say they have experience of it.

4 Apr 2005

Tarvacin shows significant anti-viral activity

Peregrine Pharmaceuticals today announced that there will be two presentations, April 4 and 6, at the American Association of Immunologists (AAI) annual meeting in San Diego, California, indicating the anti-viral potential of its Tarvacin antibody. Dr. Melina Soares of The University of Texas Southwestern Medical Center at Dallas will present pre-clinical data titled "Targeting inside-out phospholipids on viruses in a guinea pig model of Lassa fever."

4 Apr 2005

New chemicals to inhibit HIV infection

In corporation with peers from the Mount Sinai School of Medicine, New York University, researchers from the University of Science and Technology of China (USTC), a CAS affiliate, have come up with new chemical inhibitors against HIV reproduction, marking a significant progress in the development of anti-AIDS drugs based on natural host resistance.

4 Apr 2005

HHS awards $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines

United States Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines for the U.S.

3 Apr 2005

Chronic pain treatments more effective when taken together

People suffering from chronic, debilitating pain caused by nerve damage or disease report better pain relief at lower doses of a combined drug treatment than from either drug administered individually, a new Queen’s study funded by the Canadian Institutes of Health Research (CIHR) shows.

3 Apr 2005

Researchers show role of Epstein-Barr virus in cancer

Researchers at the University of Toronto have mapped the molecular details that show how a viral protein coded in the Epstein-Barr virus immortalizes cells and causes them to continuously grow, thereby predisposing people to certain types of cancer.

3 Apr 2005

Stress may enhance the body's ability to fight the flu

Short bouts of intense social stress improved the ability in the mice to recover from the flu. The stress apparently did so by substantially boosting the production of specialized immune cells that fought the virus.

3 Apr 2005

Late developers more at risk from sexually transmitted disease

Researchers at the Academic Unit of Obstetrics and Gynaecology, St Mary's Hospital, Manchester, UK, have found that late developers may run a higher risk of infection than sexually mature younger teens.

From The University of Manchester 3 Apr 2005

Polio is near total eradication

Almost 50 years after the discovery of the polio vaccine, experts think total eradication of the disease is near.

30 Mar 2005

CDC experts sent to Angola to help with Marburg epidemic

In an effort to control the Marburg virus outbreak in Angola, Health officials from the Centers for Disease Control and Prevention in Atlanta will assist the World Health Organization by going to Angola to help with outbreak investigation, infection control and laboratory diagnosis of the disease.

30 Mar 2005

Primary health care providers should incorporate HIV testing into routine patient care for all sexually active individuals

Primary health care providers should incorporate human immunodeficiency virus (HIV) testing into routine patient care for all sexually active individuals, regardless of risk factors, say a group of physician/researchers at Emory University School of Medicine, Brown Medical School, and the Johns Hopkins School of Medicine.

30 Mar 2005

New drug to treat chronic hepatitis B

The U.S. Food and Drug Administration (FDA) has given approval for a new drug to treat the potentially life-threatening disease Chronic hepatitis B.

30 Mar 2005

HIV patients who delay seeking care are much sicker when they begin care

Patients recently diagnosed with human immunodeficiency virus (HIV) are significantly more likely to seek medical treatment if they are followed even briefly by a case manager, according to findings of the national Antiretroviral Treatment Access Study (ARTAS).

30 Mar 2005

REPLICor to disclose unique antiviral drug

REPLICor Inc., a privately owned biopharmaceutical company, is developing a broad spectrum antiviral drug called REP 9 which has the broadest spectrum of activity in vitro ever reported for a single chemical entity.

30 Mar 2005

Democratic Republic of Congo on alert for Marburg epidemic

Health officials in Angola are saying the outbreak of the Ebola-like Marburg virus has claimed a record toll of 126, but the government said the number of dead was lower.

29 Mar 2005